Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

March 31, 2005

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Tetanus-diphtheria toxoids (Td)

BIOLOGICAL

7-valent pneumococcal conjugate vaccine

BIOLOGICAL

23-valent polysaccharide vaccine

Trial Locations (1)

30322

Emory University School of Medicine, Atlanta

All Listed Sponsors
collaborator

Emory University

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT00164411 - Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine | Biotech Hunter | Biotech Hunter